Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

CAPS Rating: 2 out of 5

A biopharmaceutical company building an oncology business by developing and commercializing innovative therapies that target the molecular mechanisms implicated in cancer.

Recs

1
Player Avatar withoutlimits (80.37) Submitted: 12/12/2007 3:10:27 PM : Underperform Start Price: $55.53 ONXX Score: -54.44

I think it has exceed a reasonable price in the short term.

Featured Broker Partners


Advertisement